Table 3 Breast Cancer Related Cumulative Charges by Receptor Status and Charge Type
From: Estimation of healthcare‐related charges in women with BRCA mutations and breast cancer
| Health care charges ($US) |
HER2 + ER+/PR+/HER2 + or ER-/PR-/HER2 + n = 142 |
HER2- TNBC or ER+/PR+/HER2- n = 521 | HER2 + vs. HER2- | ||
|---|---|---|---|---|---|
|
Mean
(SD) |
Median
(IQR) |
Mean
(SD) |
Median
(IQR) | p-value | |
| Facilities/ Technical |
36,523 (28,082) |
34,647 (39,683) |
28,707 (26,418) |
24,207 (32,460) | 0.00 |
| Physician/ Professional |
18,191 (14,195) |
16,138 (17,411) |
15,648 (12,973) |
12,577 (17,458) | 0.04 |
| Pharmacy |
101,145 (94,243) |
10,1374 (147,132) |
25,529 (39,646) |
7,303 (42,884) | < 0.0001 |
| Total Anticancer Treatment |
82,890 (81,269) |
81,783 (127,300) |
7,929 (21,782) |
1,364 (6,006) | < 0.0001 |
| Clinical Trial |
96 (430) |
0 (0) |
39 (199) |
0 (0) | 0.26 |
| Chemotherapy |
10,443 (15,582) |
4,417 (14,415) |
6,222 (13,642) |
1,074 (5,461) | < 0.0001 |
| Hormonal Therapy |
496 (3,889) |
0 (0) |
935 (5,660) |
0 (0) | 0.46 |
| Biologic Therapy |
71,855 (72,075) |
6,5471 (117,006) |
732 (12,692) |
0 (0) | < 0.0001 |
| Other Medication(s) |
18,255 (21,988) |
6,517 (29,473) |
17,600 (25,321) |
2,953 (29,228) | 0.02 |